We determine serum total cholesterol and high-density lipoprotein cholesterol (HDL-C) using a modified Technicon Auto Analyzer II-BMC enzymic system. The method uses 25 microL of sample (serum or supernate) for cholesterol determinations. Pooled serum which was calibrated indirectly against CDC's Abell-Kendall method was used for standardization. Accuracy and precision for total cholesterol determinations are comparable to those obtained using a modified Technicon AAII method. Coefficients of variation for the determination of HDL-C prepared by heparin/Mn++ precipitation are 6.4% and 4.6% at concentration levels of 0.70 mmol/L and 0.94 mmol/L respectively. The interchangeable use of deionized-distilled water and 0.15 mol/L NaCl solution for dilution of samples analyzed by the micro method is shown to produce significantly different cholesterol estimates. The reduced reagent volumes significantly lower the cost of cholesterol determinations. The system is simple, inexpensive and yields reliable cholesterol and HDL-C results.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0009-9120(85)80096-5 | DOI Listing |
Pak J Med Sci
January 2025
Amirah Alhowiti Assistant Professor of Family Medicine, Department of Family and Community Medicine, Faculty of Medicine, University of Tabuk, Saudi Arabia.
Objectives: Dyslipidemias are major risk factors for cardiovascular disease, and other comorbidities. The focus on food and nutrition to prevent and treat cardiovascular risk factors including dyslipidemia is a paradigm shift. This is the first meta-analysis to assess the association of dates fruit and dyslipidemia in Type-2 diabetes.
View Article and Find Full Text PDFJ Hepatocell Carcinoma
January 2025
Department of Medical Oncology, Peking University International Hospital, Beijing, People's Republic of China.
Background: The prognosis is extremely troubling in advanced hepatocellular carcinoma (HCC). Prognostic scores have been developed. Yet, the positive predictive values might appear inadequate.
View Article and Find Full Text PDFRev Cardiovasc Med
January 2025
Department of Clinical and Experimental Pharmacology, Faculty of Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland.
Lipoprotein(a) (Lp(a)) serum concentration plays a crucial role as a risk factor in cardiovascular diseases and is gaining more and more attention. Patients with elevated lipoprotein(a) levels are often prescribed statins as they also have high concentrations of low-density lipoprotein cholesterol (LDL-C). Statins are drugs that successfully decrease LDL-C, but their effectiveness in Lp(a) levels reduction is uncertain.
View Article and Find Full Text PDFRev Cardiovasc Med
January 2025
Department of Cardiology Center, Hebei General Hospital, 050051 Shijiazhuang, Hebei, China.
Background: Heart failure (HF) remains a global challenge with disappointing long-term outcomes. Malnutrition is prevalent in patients with HF and disrupts the equilibrium of immune and inflammatory responses, resulting in further deterioration of the HF. Novel indicators emerge as immune nutrition indices, including the prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), Controlling Nutritional Status (CONUT) score, and cholesterol-modified prognostic nutritional index (CPNI).
View Article and Find Full Text PDFRev Cardiovasc Med
January 2025
Department of Cardiology, Hospital Clinico Universitario de Valencia, 46010 Valencia, Spain.
Background: Exercise-based cardiac rehabilitation programs (CRP) are recommended for patients following acute coronary syndrome to potentially improve high-density lipoprotein cholesterol (HDL-C) levels and prognosis. However, not all patients reach target HDL-C levels. Here we analyze the dynamics and predictors of HDL-C increase during CRP in patients following ST-segment elevation myocardial infarction or occlusion myocardial infarction.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!